BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dennis BB, Naji L, Jajarmi Y, Ahmed A, Kim D. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World J Gastroenterol 2021; 27(29): 4818-4830 [PMID: 34447228 DOI: 10.3748/wjg.v27.i29.4818]
URL: https://www.wjgnet.com/1007-9327/full/v27/i29/4818.htm
Number Citing Articles
1
Michelle G. Brown, John F. Lindo, Ivan E. Vickers, Kereann Nelson, Yakima Phillips, Cameil Wilson-Clarke, Samuel Gavi, Gene D. Morse, Andrew H. Talal. Seroprevalence and Genotype Diversity of Hepatitis C Virus in the Caribbean—A ReviewTropical Medicine and Infectious Disease 2023; 8(7): 370 doi: 10.3390/tropicalmed8070370
2
Arwa Mohammed Othman, Asma’a Ahmed Al-hnhna, Belques Sharaf Al-Huraibi, Rowa Mohammed Assayaghi, Talal Yahya Al-Qahtani, Kamal Hamoud Jahzar, Marwan Mohammed Al-Huthaifi. Prevalence of hepatitis C virus among patients with arthralgia: is it logic for screening?Virology Journal 2023; 20(1) doi: 10.1186/s12985-023-02124-w
3
A. I. Gubenko, D. V. Goryachev, A. I. Muravieva, G. V. Shukshina. Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis CBulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation 2023; 13(4): 519 doi: 10.30895/1991-2919-2023-499
4
Muhammad Radzi Abu Hassan, Huan-Keat Chan, Mahani Nordin, Ranimah Yahya, Wan Ruzilasalwa Wan Sulaiman, Siti Aminah Akbar Merican, Darisah Lah, Xiaohui Sem, Sonjelle Shilton. Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugsHarm Reduction Journal 2023; 20(1) doi: 10.1186/s12954-023-00780-3
5
Rocio Nunez-Torres, Guillermo Pita, María Peña-Chilet, Daniel López-López, Jorge Zamora, Gema Roldán, Belén Herráez, Nuria Álvarez, María Rosario Alonso, Joaquín Dopazo, Anna Gonzalez-Neira. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical ImpactPharmaceutics 2023; 15(4): 1286 doi: 10.3390/pharmaceutics15041286
6
Shelley N. Facente, Rachel Grinstein, Roberta Bruhn, Zhanna Kaidarova, Erin Wilson, Jennifer Hecht, Katie Burk, Eduard Grebe, Meghan D. Morris, Pierre Roques. Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019PLOS ONE 2022; 17(5): e0267902 doi: 10.1371/journal.pone.0267902
7
Ghirmay Ghebrekidan Ghebremeskel, Michael Berhe Solomon, Oliver Okoth Achila, Samuel Tekle Mengistu, Rahel Frezghi Asmelash, Araia Berhane Mesfin, Mohammed Elfatih Hamida. Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in EritreaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47258-7
8
Ruiyuan Yang, Kexin Li, Cailun Zou, Aileen Wee, Jimin Liu, Liwei Liu, Min Li, Ting Wu, Yu Wang, Zikun Ma, Yan Wang, Jingyi Liu, Ang Huang, Ying Sun, Binxia Chang, Qingsheng Liang, Jidong Jia, Zhengsheng Zou, Xinyan Zhao. Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver InjuryFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.934467